Keyphrases
Phase I Study
100%
AIDS/HIV
100%
Acyclovir
100%
Zidovudine
100%
Virus
25%
Long-term Efficacy
25%
Clinical Data
25%
Safety Impact
25%
San Francisco
25%
HIV Status
25%
Pharmacokinetic Effects
25%
Drug Interactions
25%
Immunological Effects
25%
Lymphocytes
25%
Bisexual Men
25%
Virologic
25%
Peripheral Blood
25%
Long Follow-up
25%
Skin Test
25%
Pharmacokinetic Analysis
25%
Homosexual Men
25%
Pharmacokinetic Data
25%
Human Immunodeficiency
25%
Safety Tolerance
25%
Immunodeficiency Diseases
25%
Hematologic Parameters
25%
Large Trials
25%
Long-term Tolerance
25%
Tolerance Effect
25%
Antiretroviral Activity
25%
Total Leukocytes
25%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Aciclovir
100%
Zidovudine
100%
Pharmacokinetics
75%
Cohort Study
25%
Immune Deficiency
25%
Disease
25%
Drug Interaction
25%